検索結果

Company Profile | About Senju | SENJU Pharmaceutical

512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi...

xam Co., Ltd. (hereinafter “Rexxam”). 3in1 Smart is a compact all-in-one unit that integrates refractometry, keratometry, and tonometry into a single device, consolidating essential functions in a spa...

xam Co., Ltd. (hereinafter “Rexxam”). 3in1 Smart is a compact all-in-one unit that integrates refractometry, keratometry, and tonometry into a single device, consolidating essential functions in a spa...

Publications | Research & Development | SENJU Pharmaceutica

cebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, J...

千寿製薬株式会社

or Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has develo...